Clinical Trial Update: Prevention of Cardiac Dysfunction During Breast Cancer Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating prevention of cardiac dysfunction during breast cancer therapy; status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Heart Failure

Snippet

Sponsor: Torbjorn Omland | Conditions: Breast Cancer Female, Heart Failure | Phase 2 | Status: COMPLETED